StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.87+0.01 (+0.09%)

Close on Nov 17, 2026Market cap $209.89MP/E –Yield –

Translational Development Acquisition operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Translational Development Acquisition's operating cash flow for the twelve months ending Jun 30, 2026 was -$849.38K. For fiscal 2025 it was -$608.39K.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$608.39K–
FY2024Dec 31, 2024-$851.45K–
FY2023Dec 31, 2023-$204–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$338.75K–
Q1 FY2026Mar 31, 2026-$305.16K–
Q4 FY2025Dec 31, 2025-$117.36K–
Q3 FY2025Sep 30, 2025-$88.11K–
Q2 FY2025Jun 30, 2025-$171.35K–
Q1 FY2025Mar 31, 2025-$231.57K–
Q4 FY2024Dec 31, 2024-$810.96K–

More Translational Development Acquisition figures

See a number that looks wrong?